EA201070160A1 - Фармацевтическая композиция, содержащая дигидропиридиновый антагонист кальциевого канала, и способ её приготовления - Google Patents

Фармацевтическая композиция, содержащая дигидропиридиновый антагонист кальциевого канала, и способ её приготовления

Info

Publication number
EA201070160A1
EA201070160A1 EA201070160A EA201070160A EA201070160A1 EA 201070160 A1 EA201070160 A1 EA 201070160A1 EA 201070160 A EA201070160 A EA 201070160A EA 201070160 A EA201070160 A EA 201070160A EA 201070160 A1 EA201070160 A1 EA 201070160A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
calcium channel
pharmaceutical composition
composition containing
dihydropyridine
Prior art date
Application number
EA201070160A
Other languages
English (en)
Other versions
EA021645B1 (ru
Inventor
Евангелос Каравас
Эфсимиос Коутрис
Иоанна Коутри
Елени Стасаки
Original Assignee
Фарматен С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201070160(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Фарматен С.А. filed Critical Фарматен С.А.
Publication of EA201070160A1 publication Critical patent/EA201070160A1/ru
Publication of EA021645B1 publication Critical patent/EA021645B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Данное изобретение относится к составу твердых лекарственных форм, включающих терапевтически эффективное количество дигидропиридинового антагониста кальциевого канала, такого как лерканидипин или его соль, в комбинации с коллоидным кремния диоксидом, таким как Aerosil™, для увеличения биодоступности и улучшения растворимости, и способу его приготовления влажной грануляцией.
EA201070160A 2007-07-23 2007-07-23 Твердая дозированная форма в виде таблетки и способ её приготовления EA021645B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (2)

Publication Number Publication Date
EA201070160A1 true EA201070160A1 (ru) 2010-06-30
EA021645B1 EA021645B1 (ru) 2015-08-31

Family

ID=39223083

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201070160A EA021645B1 (ru) 2007-07-23 2007-07-23 Твердая дозированная форма в виде таблетки и способ её приготовления
EA201000220A EA019614B1 (ru) 2007-07-23 2008-07-23 Усовершенствованная фармацевтическая композиция, содержащая антагонист дигидропиридинкальциевого канала, и способ ее получения

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201000220A EA019614B1 (ru) 2007-07-23 2008-07-23 Усовершенствованная фармацевтическая композиция, содержащая антагонист дигидропиридинкальциевого канала, и способ ее получения

Country Status (20)

Country Link
EP (2) EP2180883B1 (ru)
JP (2) JP5769963B2 (ru)
KR (2) KR101632079B1 (ru)
CN (3) CN101784260A (ru)
AU (2) AU2007356942B2 (ru)
BR (2) BRPI0721883A2 (ru)
CA (2) CA2691752C (ru)
CO (1) CO6290639A2 (ru)
CR (1) CR11285A (ru)
EA (2) EA021645B1 (ru)
EC (1) ECSP109984A (ru)
ES (2) ES2622495T3 (ru)
MA (1) MA31684B1 (ru)
MX (2) MX2010000856A (ru)
MY (1) MY153857A (ru)
NZ (2) NZ582648A (ru)
TN (2) TN2010000011A1 (ru)
UA (2) UA97161C2 (ru)
WO (2) WO2009012791A1 (ru)
ZA (2) ZA201000586B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
NZ582648A (en) * 2007-07-23 2012-06-29 Pharmathen Sa Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
WO2010114928A2 (en) * 2009-04-03 2010-10-07 F.Hoffmann-La Roche Ag Compositions and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
ZA200605290B (en) * 2003-12-01 2007-10-31 Lifecycle Pharma As Pharmaceutical compositions comprising lercanidipine
BRPI0417043A (pt) * 2003-12-01 2007-02-06 Lifecycle Pharma As composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
CA2662123C (en) * 2006-08-30 2015-12-01 Jagotec Ag Controlled release oral dosage formulations comprising a core and one or more barrier layers
EP2101771A2 (en) * 2006-12-06 2009-09-23 Torrent Pharmaceuticals Ltd Stable lercanidipine formulation
NZ582648A (en) * 2007-07-23 2012-06-29 Pharmathen Sa Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Also Published As

Publication number Publication date
KR101512404B1 (ko) 2015-04-21
CN101801347A (zh) 2010-08-11
KR20100047848A (ko) 2010-05-10
BRPI0814666A2 (pt) 2017-05-09
ZA201000586B (en) 2011-03-30
CA2691752C (en) 2016-01-26
UA97161C2 (ru) 2012-01-10
EP2170295B1 (en) 2015-04-22
CA2693233A1 (en) 2009-01-29
TN2010000011A1 (en) 2011-09-26
JP2010534211A (ja) 2010-11-04
JP5769963B2 (ja) 2015-08-26
CN103976968A (zh) 2014-08-13
WO2009013306A1 (en) 2009-01-29
AU2008280106A2 (en) 2010-02-25
AU2008280106A1 (en) 2009-01-29
TN2010000022A1 (en) 2011-09-26
EA021645B1 (ru) 2015-08-31
KR101632079B1 (ko) 2016-06-20
NZ582690A (en) 2011-12-22
ES2537063T3 (es) 2015-06-02
EA019614B1 (ru) 2014-05-30
JP2010534220A (ja) 2010-11-04
CN101784260A (zh) 2010-07-21
AU2007356942A1 (en) 2009-01-29
AU2008280106B2 (en) 2014-03-20
MY153857A (en) 2015-03-31
MX2010000801A (es) 2010-07-05
ZA201001176B (en) 2010-11-24
MA31684B1 (fr) 2010-09-01
EA201000220A1 (ru) 2010-08-30
NZ582648A (en) 2012-06-29
ES2622495T3 (es) 2017-07-06
EP2180883B1 (en) 2017-01-11
CR11285A (es) 2010-04-27
MX2010000856A (es) 2010-04-30
AU2008280106B9 (en) 2014-08-07
BRPI0721883A2 (pt) 2014-02-18
UA99136C2 (ru) 2012-07-25
WO2009012791A1 (en) 2009-01-29
AU2007356942B2 (en) 2011-12-15
ECSP109984A (es) 2010-04-30
CA2691752A1 (en) 2009-01-29
EP2170295A1 (en) 2010-04-07
KR20100045456A (ko) 2010-05-03
CO6290639A2 (es) 2011-06-20
EP2180883A1 (en) 2010-05-05

Similar Documents

Publication Publication Date Title
EA201070160A1 (ru) Фармацевтическая композиция, содержащая дигидропиридиновый антагонист кальциевого канала, и способ её приготовления
EA201170958A1 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
ATE536172T1 (de) Ezetimibzusammensetzungen
EA201170483A1 (ru) Твердая фармацевтическая композиция
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
CY1109753T1 (el) ΑΛΑΣ (2R,4aR,10bR) - 6 - (2,6-ΔΙΜΕΘΟΞΥ-ΠΥΡΙΔΙΝ-3-ΥΛ)- 9- ΑΙΘΟΞΥ - 8- ΜΕΘΟΞΥ - 1,2,3,4,4a,10b - ΕΞΑΫΔΡΟ-ΦΑΙΝΑΝΘΡΙΔΙΝ - 2 - ΟΛΗ ΥΔΡΟΧΛΩΡΙΟΥ
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
PH12017501397A1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
WO2014016754A3 (en) Pharmaceutical compositions of proton pump inhibitor
EA201001353A1 (ru) Гидробромид ивабрадина
EA200900463A1 (ru) Арипипразола гемифумарат и способ его получения
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин
PL401632A1 (pl) Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ